Company Overview of Aventis S.A.
As of August 30, 2004, Aventis S.A. was acquired by Sanofi-Synthelabo S.A. Aventis S.A. is engaged in the discovery, development, manufacture, and marketing of branded prescription drugs and human vaccines. Its products were used for treating lung and breast cancer, thrombosis, seasonal allergies, diabetes and hypertension in the European Union, the United States, and the Asia-Pacific region. Aventis S.A. was founded in 1900 and is based in Strasbourg, France.
Espace Europeen de l'Entreprise
16 avenue de l'Europe Cedex 9
Founded in 1900
33 3 88 99 11 00
33 1 47 68 19 11
Key Executives for Aventis S.A.
Aventis S.A. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Key Neurosciences SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Aventis S.A., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.